Fabio Eisfeld: Plasma-derived Drugs Cannot Be Produced Synthetically, They Depend Entirely On The Generosity of Healthy Donors
Fabio Eisfeld, HR Manager Latam at Grifols, shared on LinkedIn:
”Last week, we celebrated International Plasma Awareness Week (IPAW2025 ), and Grifols employees in Latin America actively participated!
Here are photos of colleagues dressed in yellow to contribute to this important moment.
Created by the Plasma Protein Therapeutics Association (PPTA), IPAW is dedicated to highlighting the value of human plasma, recognizing the generosity of donors, and promoting understanding of plasma-derived therapies.
Plasma-derived drugs cannot be produced synthetically; they depend entirely on the generosity of healthy donors.
These donations provide essential proteins, which often represent the only therapy available to patients.
Millions of people around the world, both those suffering from rare and chronic diseases and those facing trauma or medical emergencies, rely on plasma-derived therapies.
We remain firm in our goal: to produce and deliver medicines that provide quality of life to our patients!”
-
Apr 15, 2026, 15:01Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory
-
Apr 15, 2026, 14:55Donald Correll: Key Risk Factors for Venous Thromboembolism
-
Apr 15, 2026, 14:48Fadwa Said Abdelazim: Is Vaping Really ‘Safer’ for the Blood Than Smoking?
-
Apr 15, 2026, 14:42Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
-
Apr 15, 2026, 14:42Caitlin Raymond: Augmented Intelligence Enhancing Human Capability Without Replacement
-
Apr 15, 2026, 14:39Pooja Choradia: Recognizing Pulmonary Embolism in Pregnancy Before It Is Too Late
-
Apr 15, 2026, 14:38Alessandra Bosch։ Understanding Haemostasis in Children and Its Challenges
-
Apr 15, 2026, 14:29Joseph Caprini: The Future of VTE Care Is Shifting from Static Risk to Digital Twins
-
Apr 15, 2026, 14:25Prince Alfred Singh։ Understanding Antithrombin III Deficiency as a High-Risk Thrombophilia